SCHEMBL15034686

SCHEMBL15034686

Cc1cc(C(N)c2ncccc2C(F)(F)F)ccc1F

nearest known ligand 0.42

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
▸ TRPM8 Q7Z2W7 18/20 0.42
▸ PRKDC P78527 1/20 0.35
▸ WDR5 P61964 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14405600 0.88 TRPM8 (0.45) TRPM8
SCHEMBL14334290 0.85 TRPM8 (0.56) TRPM8
SCHEMBL14334289 0.85 TRPM8 (0.56) TRPM8
SCHEMBL14407023 0.85 S1PR3 (0.38) TRPM8
SCHEMBL15034692 0.85 S1PR3 (0.38) TRPM8
Hydrochloric Acid SCHEMBL14333124 0.84 TRPM8 (0.55) TRPM8
Hydrochloric Acid SCHEMBL14333126 0.84 TRPM8 (0.55) TRPM8
SCHEMBL14406986 0.82 TRPM8 (0.50) TRPM8
SCHEMBL14406977 0.82 TRPM8 (0.50) TRPM8
SCHEMBL14405534 0.81 TRPM8 (0.53) TRPM8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20140235642-A1 TRPM8 ANTAGONISTS AND THEIR USE IN TREATMENTS AMGEN INC. (US) 2014-08-21 — — US disclosed
US-8778941-B2 TRPM8 antagonists and their use in treatments AMGEN INC. (US) 2014-07-15 — — US disclosed
US-20130158034-A1 TRPM8 ANTAGONISTS AND THEIR USE IN TREATMENTS AMGEN INC. (US) 2013-06-20 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130158034-A1 TRPM8 ANTAGONISTS AND THEIR USE IN TREATMENTS TRPM8, TRPM7, TRPM5 TRPM8 1/4885PRKDC 2888/4885WDR5 3350/4885
US-20140235642-A1 TRPM8 ANTAGONISTS AND THEIR USE IN TREATMENTS TRPM8, TRPM7, TRPM5 TRPM8 1/4885PRKDC 2888/4885WDR5 3350/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback